Julie Fisher is Senior Vice President, European Commercialization. View All Management Team
Ms. Fisher joined Acadia in 2018 as Executive Director, New Product Planning and Commercial Strategy and was promoted to Vice President of Marketing in 2020 to lead the NUPLAZID® (pimavanserin) brand strategy. She then moved into Senior Vice President, Marketing & Commercial Strategy in 2021 and in 2024, she oversees the cross-functional global commercial operations throughout Europe.
Ms. Fisher is an accomplished biopharmaceutical executive with over three decades of experience focused almost exclusively in central nervous system (CNS) disorders. She started her career at Pfizer and held a variety of roles with increasing responsibility in marketing, brand leadership and global commercial strategy. Julie served as Vice President of Pfizer’s multi-billion dollar U.S. CNS franchise that included ZOLOFT® and Aricept®. In addition, she led commercial strategy for the psychiatry pipeline.
Ms. Fisher also worked at APS Healthcare/Universal American, a care management and Medicare Advantage organization focused on optimizing care and managing costs for Medicaid and Medicare for people with mental illness. Prior to joining Acadia, she was the Vice President of Global Commercial Development at Axovant in preparation for the introduction of a new Alzheimer’s compound.